Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9650-9656
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9650
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9650
Table 3 Incidence of adverse reactions in the two groups after the treatment, n (%)
Groups | Nausea and vomiting | Pain | Fever |
Observation group, n = 30 | 9 (30.00) | 21 (70.00) | 11 (36.67) |
Control group, n = 30 | 19 (63.33) | 22 (73.33) | 12 (40.00) |
χ2 value | 6.421 | 0.245 | 0.312 |
P value | 0.035 | 0.543 | 0.564 |
- Citation: Zhang C, Dai YH, Lian SF, Liu L, Zhao T, Wen JY. Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer. World J Clin Cases 2022; 10(27): 9650-9656
- URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9650.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9650